Cann Group Ltd has released a press release.
Cann executes MOU with Under The Tree Biopharmaceuticals
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cann
- Granting of New Research and Medicinal Cannabis Licences
- Appendix 4D to Half Yearly Report and Accounts
- Federal Government Announcement on Medicinal Cannabis Export
- Cann Group Successfully Completes Placement
- Fully underwritten $60 million capital raise
Later from Cann
- Receipt of Import Permits for Genetics and Cannabis Oil
- S&P DJ Indices Announces March Quarterly Rebalance
- Leading Global Consultancy appointed for Phase 3 facility
- Quarterly Activities Report and Appendix 4C
- Takeover speculation in the media
Follow Cann into a list and get an email when it puts out news.
Follow Cann